Grossman William

Track

Insider profile

Performance

Overall performance
3.4
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 96% 68% 82%
Transactions
5 80% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 194%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Grossman William's trades of enGene Therapeutics Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
272.21
Quantity 4,927 +19.9%
Value US$2,542,504
Transaction date
Planned sale
Price
31.35
Quantity 2,117 -23.9%
Value US$66,368
Transaction date
Purchase
Price
19.68
Quantity 100 +20.0%
Value US$1,968
Transaction date
Purchase
Price
19.77
Quantity 100 +25.0%
Value US$1,977
Transaction date
Purchase
Price
8.00
Quantity 300 +300.0%
Value US$2,400
Transaction date
Purchase
Price
8.00
Quantity 100 +inf%
Value US$800
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-24 2026-09-22
B Purchase
4,927 +19.9%
272.21
US$2,542,504 		4,927 +19.9% 272.21 US$2,542,504
2021-04-26 2021-04-23
S Sale
89,470 -16.2%
133.29
US$820,848 		89,470 -16.2% 133.29 US$820,848
2021-03-18 2021-03-16
S Sale
73,163 +6.1%
373.53
US$1,476,874 		73,163 +6.1% 373.53 US$1,476,874
2020-12-18 2020-12-16
PlS Planned sale
2,117 -23.9%
31.35
US$66,368 		2,117 -23.9% 31.35 US$66,368
2020-08-04 2020-07-31
B Purchase
100 +20.0%
19.68
US$1,968 		100 +20.0% 19.68 US$1,968
2020-08-04 2020-07-31
B Purchase
100 +25.0%
19.77
US$1,977 		100 +25.0% 19.77 US$1,977
2019-10-15 2019-10-14
B Purchase
300 +300.0%
8.00
US$2,400 		300 +300.0% 8.00 US$2,400
2019-10-15 2019-10-10
B Purchase
100 +inf%
8.00
US$800 		100 +inf% 8.00 US$800